Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Joseph R Francica

10PUBLICATIONS

166CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsNanomedicineInnate immunityGene and molecular therapyPacific Peoples biomedical and clinical science

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Oct 21, 2025

Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial.

Pablo Tebas, Ami Patel, Joseph T Agnes

|Aug 28, 2025

SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody Responses.

Johnathan D Guest, Yi Zhang, Daniel Flores

|Apr 23, 2025

FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite protein.

Neville K Kisalu, Lais D Silva Pereira, Jonathan D Herman

|Mar 28, 2025

Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape.

Fangqiang Zhu, Saravanan Rajan, Conor F Hayes

|Jun 26, 2024

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.

Yingyun Cai, Seme Diallo, Kim Rosenthal

|Jan 03, 2024

Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.

Madhu Prabhakaran, Flavio Matassoli, David Leggat

Pageof 2

Frequent Collaborators

6 joint publications

Robert A Seder

3 joint publications

Azza H Idris

3 joint publications

Brian G Bonilla

3 joint publications

Adrian McDermott

3 joint publications

Patience Kiyuka

3 joint publications

Peter D Kwong

3 joint publications

Marlon Dillon

3 joint publications

Kizzmekia S Corbett-Helaire

3 joint publications

Yingyun Cai

3 joint publications

John-Paul M Todd

Frequent Collaborators

6 joint publications

Robert A Seder

3 joint publications

Azza H Idris

3 joint publications

Brian G Bonilla

3 joint publications

Adrian McDermott

Top Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on : May 02, 2011

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos

Top Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on : May 02, 2011

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos